Ronald Kirk Huntsman - 21 Sep 2021 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role: Chief Executive Officer, Director
Signature: /s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
Issuer symbol: VVOS
Transactions as of: 21 Sep 2021
Net transactions value: +$21,550
Form type: 4
Filing time: 22 Sep 2021, 15:09:28 UTC
Previous filing: 18 Aug 2021
Next filing: 14 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VVOS	Common Stock	Purchase	$21,550	+5,000	+48%	$4.31^*	15,500	21 Sep 2021	Direct
holding	VVOS	Common Stock						1,740,000	21 Sep 2021	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VVOS	Stock Option (Right to Buy)						333,334	21 Sep 2021	Common Stock	333,334	$1.65	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
F2	The option provides for vesting in five equal annual installments beginning on January 15, 2017.